Lipoprotein (a) has a prothrombic role in the pathogenesis of CAD due to its structural homology with plasminogen and it has been hypothesised that the former interferes with plasminogen activation and creates a thrombogenic milieu. This evidence concerns the gene PLG and coronary artery disorder.